Astria Therapeutics gains as quarterly loss narrows

Astria Therapeutics

22/03/2023 18:06

** Shares of biopharmaceutical company Astria Therapeutics
Inc  ATXS.O  up 3.1% at $11.57 
    ** Co reports quarterly loss of 72 cents/share, smaller than
74 cents/share a year earlier
    ** As of Dec. 31, 2022, ATXS had cash, cash equivalents, and
short-term investments of $226.4 mln 
    ** Co expects to have sufficient cash to fund current
operating plans through first half of 2025
    ** All six brokerages covering the stock rate it "buy" or
higher - Refinitiv data
    ** ATXS shares nearly tripled in value last year

 (Reporting By Akshita Toshniwal)
 ((Akshita.Toshniwal@thomsonreuters.com))